Logan Capital Management’s Zimmer Biomet ZBH Stock Holding History

Logan Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.67M	Buy	+18,500	New	+$1.7M	0.07%	177

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Logan Capital Management's ZBH Position: Q1 2026 in Review

Logan Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 18,500 shares — an estimated $1.7M sold.

Logan Capital Management first reported a position in ZBH in Q2 2013 and held it in 51 quarters. The position peaked at $3.7M in Q1 2015. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Logan Capital Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
Logan Capital Management sold 18,500 Zimmer Biomet shares in Q1 2026, an estimated $1.7M.
Logan Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 51 quarters.
Logan Capital Management's Zimmer Biomet position peaked at $3.7M in Q1 2015.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.